Antibody Technologies

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology | Antibody Technologies

Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017

Price

Publication Date: 01-Feb-2012
Format: PDF
Pages: 290
Publisher: GBI Research
More...

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth

Price

Publication Date: 17-Sep-2011
Format: PDF
Pages: 121
Publisher: GBI Research
More...

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

Price

Publication Date: 01-Dec-2011
Format: PDF
Pages: 172
Publisher: GBI Research
More...

Competitor Analysis: Anti-Infective Antibodies

Price

Publication Date: Nov 2011
Format: PDF
Pages: 160
Publisher: La Merie

The present Competitive Intelligence Report about Anti-Infective Antibodies provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies and human plasma-derived immunoglobulins and hyperimmunes for post-exposure prophylaxis and treatment of infectious diseases as of November 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
More...

Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis

Price

Publication Date: September 2011
Format: PDF
Pages: 274
Publisher: La Merie

This report provides the most complete compilation of information about antibody-drug conjugate (ADC) companies, technologies and products in R&D. A comprehensive analysis of the state of the art and key trends guides the reader through this complex subject. Stakeholders in the field of antibody-drug conjugates are analysed and their contribution to the growth ADC technology and products is assessed. A critical appraisal of the clinical results of active and discontinued ADC projects and products is provided. ADC technologies and products are challenged for their commercial value and growth potential.
More...

Monoclonal Antibodies: 2010 Price: $7,600.00 (€5,782.51) ($9,120.00 (€6,939.02) Including VAT at 20%)
Publication Date: 07-Oct-2010 Please click here for more information or to purchase this report at our partner store Historical and forecast analysis of the monoclonal antibodies sector from 2003 through to 2015.

Competitor Analysis Antibody Therapy of Inflammatory and Autoimmune Diseases

Price

Publication Date: Dec 2010
Format: PDF
Pages: 172
Publisher: La Merie

The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed for treatment of rheumatoid arthritis, psoriasis, Crohn’s disease, ulcerative colitis, multiple sclerosis, asthma and other autoimmune diseases as of December 2010. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
More...

Antibody Pipeline Database: 1-Year Subscription

Price

Publication Date: Nov 2010
Format: Online Database
Publisher: La Merie

Subscription to La Merie’s proprietary Antibody Pipeline Database provides online access to more than 1,600 project entries for therapeutic antibodies on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major products are provided. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database.

More...

Antibody Technology Companies 2010 - A systematic guide through the landscape of antibody technologies and their providers

Price

Publication Date: Nov-2010
Format: PDF
Pages: 283
Publisher: La Merie
Table of Contents
Sample Pages

The report provides a description and assessment of antibody technologies and their corporate providers as of November 2010. The report describes and analyzes the market size of therapeutic monoclonal antibodies and Fc-fusion proteins in 2009. Characteristics of approved antibody-based products regarding identification, construction and manufacturing are evaluated as a basis for relevant antibody technologies in 2010. Systematic profiles of 96 companies engaged in antibody technologies serve as the basis to present in a structured manner four clusters of platform technologies (generation, optimization, novel constructs, expression/manufacturing). The report serves as a systematic guide through the landscape of companies with antibody technologies for those in search of service providers or partners for collaboration or licensing.
More...

Competitor Analysis Biosimilar and Biobetter/Biosuperior Antibodies

Price

Publication Date: October-2010
Format: PDF
Pages: 106
Publisher: La Merie

The present Competitive Intelligence Report about Biosimilar and Biobetter/Biosuperior Antibodies provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies directed against CD20, Her2, VEGF, TNF, EGF-R, RSV and GPIIb/IIIa as of October 2010. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
More...

Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects

Please click here for more information or to purchase this report at our partner store

Published: July 2010
Format: PDF
Pages: 183

This innovative & analytical report can be used to assess market trends & appraise the potential of new antibodies & therapeutic proteins. It provides perspective to:

gain an in-depth understanding of the marketplace, players, products & leading technologies driving the field;
evaluate the unmet clinical needs, product pipelines & technological challenges for the next generation of mAbs & TPs;
identify the key regulatory, IP & reimbursement issues which face biopharmaceutical companies;
assess the therapeutic potential of new mAbs & TPs targeting cancer, immuno-inflammatory related disorders, CNS disorders & others;
identify the potential threat of biosimilars & examine their impact on the prescription & development of new biologics now & in the future;
analyze the market trends & highlight future market opportunities.

Monoclonal antibodies: 2009 update Price: $7,600.00 (€5,782.51) ($9,120.00 (€6,939.02) Including VAT at 20%)
Publication Date: 02-Nov-2009 Please click here for more information or to purchase this report at our partner store Detailed analysis of the monoclonal antibody segment, encompassing market dynamics, key therapy areas, geography, technology and target types through to 2014, evaluating the strategies companies are using to capitalize on this lucrative market

Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging technologies and new therapeutic candidates
Price: $3,835.00 (€2,917.89) ($4,602.00 (€3,501.46) Including VAT at 20%)

Publication Date: 01-Mar-2010
Please click here for more information or to purchase this report at our partner store

Monoclonal antibodies form the fastest growing segment of the pharmaceutical industry, with total annual sales expected to top $50 billion in the next four years. This report explains what monoclonal antibodies are, and why large pharmaceutical companies are investing so heavily both in developing such drugs internally and acquiring monoclonal antibody candidates from others. More than 80 popular and emerging technologies are named, explained and illustrated with original full-color diagrams.

The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

Price

Publication Date: 01-Dec-2009
Format: PDF
Pages: 132
Publisher: GBI Research
More...

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology | Antibody Technologies

Best Sellers

New Products

Antibody Technologies

Shopping Cart

Email Alerts

Events